Introduction: Regulation of cerebral blood flow (CBF) is vital for ensuring blood supply to cerebral tissue, and studies have shown that CBF increases to match the demands of whole-body exercise. Additionally, studies have shown that an inspiratory muscle metaboreflex induced by fatiguing inspiratory work causes a decrease in blood flow to limbs and splanchnic organs, presumably redirecting blood flow to the activated inspiratory muscles. However, it is unknown if the metaboreflex response is greater when targeting the diaphragm during inspiration as opposed to using all inspiratory muscles. We aimed to determine if middle cerebral artery velocity (MCAv), a surrogate for global CBF, was affected by inspiratory muscle metaboreflex, and if so, if MCAv is affected differently when targeting diaphragmatic pressure (PTL-diaphragm; PTL di ) vs targeting mouth pressure (PTL-mouth; PTL mo ). We hypothesized that MCAv will be preserved with fatiguing inspiratory work, in both PTL di and PTL mo breathing patterns. Methods: We studied 11 (5 females) participants without any cardiorespiratory, metabolic, or musculoskeletal diseases (36±9 yrs, FEV 1 /FVC: 100±8%predicted). Each participant had gastric and esophageal balloon catheters placed to measure respiratory pressures. Blood pressure was continuously recorded via finger photoplethysmography. Transcranial doppler ultrasound continuously recorded MCAv. Participants performed breathing trials through a custom-built inspiratory pressure loading (IPTL) device, designed to open when negative pressure was generated. Each trial was comprised of 15 breaths/minute, with each breath consisting of 70% inspiration and 30% expiration. Trial 1 involved 5 minutes of PTL mo targeting 60% of their maximal inspiratory pressure, and trial 2 consisted of 5 minutes of PTL di targeting 60% transdiaphragmatic pressure. CO 2 was administered during IPTL to avoid hypocapnia. Cerebrovascular conductance index (CVCi) was calculated from MCAv. A paired t-test compared the 2 trials, deltas are calculated from end task to baseline, and data are reported as mean±SD. Results: The transdiaphragmatic pressures (PTP di ) between the two trials were different (PTL mo : 5,051±2,620, PTL di : 7,082±2,200 cmH 2 O·s/min; p=0.009). The change inMAP were not different between trials (PTL mo : 8±4, PTL di : 13±9 ΔmmHg; p=0.10). There was no difference in the change in MCAv (PTL mo : 10.07±21.51, PTL di : 9.66±22.10 Δcm/s; p=0.96) or CVCi (PTL mo : 0.03±0.23, PTL di : -0.01±0.17 Δcm/s/mmHg; p=0.55) between the two trials. Conclusion: These findings suggest that the inspiratory muscle metaboreflex does not impair CBF regulation during IPTL; this is true regardless of inspiratory muscle recruitment. Further work should focus on continuing the breathing exercises until exhaustion. NIH (HL139854); NSERC (PDF-577750-2023) This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Leg Vascular Conductance During Fatiguing Inspiratory Muscle Work Is Not Different Between Females And Males
Background: Fatiguing inspiratory muscle work can trigger the sympathetically-mediated respiratory muscle metaboreflex. Activating this reflex has been shown to increase blood pressure and heart rate while decreasing peripheral blood flow. Studies have shown females have an attenuated mean arterial pressure response (MAP) compared to males despite similar workloads to fatiguing inspiratory muscle work, suggesting females may have an attenuated respiratory muscle metaboreflex. However, the sex difference effects of respiratory muscle metaboreflex effects on resting limb vascular conductance (LVC) remains unknown. The purpose of this study was to investigate whether sex differences exist in LVC responses to fatiguing inspiratory muscle work. We hypothesize that males would exhibit a greater decrease in LVC compared to females. Methods: Eight healthy females (F; 35±11 years) and 8 healthy males (M; 31±6 years) completed the study. Participants completed a 5-minute baseline followed by a 5-minute inspiratory pressure threshold loading (IPTL) trial. The breathing pattern was set to 60% of their maximal inspiratory mouth pressure with a breathing frequency of 15 breaths/minute and an inspired duty cycle of 0.7 to activate the respiratory muscle metaboreflex. CO 2 was introduced into the inspired circuit to prevent hypocapnia. Continuous MAP (finger photoplethysmography) and heart rate (electrocardiogram) were recorded. Continuous blood velocity and diameters of the superficial femoral artery were measured using duplex ultrasonography. Leg blood flow (LBF) was calculated as the product of mean blood velocity and femoral artery cross-sectional area. LVC was calculated as LBF/mean arterial pressure. These data were averaged in 30-second segments and reported from 5-minute mark of IPTL (End-Task % of baseline). Groups were compared using Student’s t -test and analyzed using a two-way repeated-measures ANOVA. Results: Pulmonary function was within predicted ranges for all participants (FEV 1 /FVC: [F vs. M]: 100±8 vs. 100±9%predicted; P=0.919). Heart rate ([Baseline: F vs. M]: 70±13 vs. 73±8 bpm; P=0.571) and MAP (Baseline: [F vs. M]: 90±12 vs. 95±8 mmHg; P=0.378) were not different between females and males at baseline or throughout the IPTL trial (Group Main Effect: p>0.05 for both). Additionally, LBF decreased in response to IPTL but there was no difference between groups (End-Task: [F vs. M]: -31±33 vs. -21±24%baseline; Time Main Effect: P=0.012, Group Main Effect: P=0.352). When accounting for blood pressure, LVC also decreased during IPTL but was not different between females and males (End-Task: [F vs. M]: -37±30 vs. -33±24%baseline; Time Main Effect: p<0.001, Group Main Effect: P=0.655). Conclusion: These preliminary data suggest LVC decreases during a 5-minute period of fatiguing inspiratory work using IPTL; however, IPTL does not elicit variable LVC decreases between females and males. NIH (HL139854); NSERC (PDF-577750-2023) This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Durability, fatigability, repeatability, and resilience in endurance sports: definitions, distinctions, and implications
Background: During acute hypoxia, Thehuman brainemploys complex regulatory mechanisms to compensate for high O 2 demand and low O 2 blood saturation. High hemoglobin-oxygen (Hb-O 2 ) affinity improves arterial oxygen saturation (S a O 2 ) in low oxygen environments providing a potential physiologic benefit in humans. However, the impact of high Hb-O 2 affinity on cerebral blood flow (CBF) and cerebral tissue oxygenation (S t O 2 ) has yet to be examined. This work aimed to determine the influence of an acute increase in Hb-O 2 affinity from Etavopivat, a selective red blood cell pyruvate kinase activator, on CBF regulation and S t O 2 during handgrip exercise in normoxia and hypoxia. Methods: 16 healthy adults (31±8 yr, 5 females) completed two visits; before and after Etavopivat (400 mg daily, 7 days) administration,. Each visit included graded handgrip (~3 min stages each) exercise (rest, 10% maximal voluntary contraction (MVC), 20% MVC) while participants inspired normoxic (NORM, 21% O 2 ), moderate (MH, 15% O 2 ), and severe (SH, 10% O 2 ) hypoxic gas mixtures. Hb-O 2 binding affinity (P 50 ), was measured using dual-wavelength spectrophotometry (pH~7.4 and 37ºC). Blood sampling through catheterization of the non-exercising arm measured S a O 2 . CBF was approximated by the peak middle cerebral artery velocity, measured with a 2MHz transcranial doppler ultrasound through the transtemporal window. S t O 2 was measured using frequency-domain near infrared spectroscopy of the frontal cortex. CBF and S t O 2 between visits were compared using separate two-way RM ANOVA models to determine the effects of Etavopivat [before (baseline) or after 7d Etavopivat exposure (post)] and exercise intensity [rest, 10% MVC, 20% MVC] for each inspirate. Results: P 50 was reduced after Etavopivat exposure (Baseline: 28.6±1.6 mmHg, Etavo: 24.8±1.3, P <0.001) without impacting hematocrit ( P =0.97). S a O 2 was higher following Etavopivat exposure during each inspirate ( P <0.001 for each). There was no significant effect of handgrip exercise on CBF or S t O 2 within any inspirate. Cerebral S t O 2 was higher during each inspirate (all P <0.002)– NORM (Baseline: 65.3±12.3%, Post: 68.8±9.8%), MH (Baseline: 61.0±11.7 %, Post: 66.1±10.5%) and SH (Baseline: 47.7±13.5%, Post: 56.6±11.5%). In addition, CBF was increased during each inspirate (all P <0.001)– NORM (Baseline: 62.2±12.2 cm/s, Post: 69.2±12.5 cm/s), MH (Baseline: 60.8±13.1 cm/s, Post: 67.9±12.3 cm/s) and SH (Baseline: 69.8±16.3 cm/s, Post: 79.2±18.0 cm/s). Conclusion: The acute pharmacological induction of high Hb-O 2 affinity leads to increased CBF and cerebral S t O 2 during acute hypoxic exposure in conditions of mild muscular exertion. Whether the improvement of cerebral S t O 2 is associated increased S a O 2 or CBF (or both) is unclear. These findings are the first to investigate the complex determinants of cerebral S t O 2 as a function of an acute increase in Hb-O 2 affinity. These improvements in S t O 2 during hypoxic exposure may lead to a host of theoretical benefits such as improved hypoxia tolerance, and mitigated decrements in cognitive function during hypoxic exposure. This study was funded by Forma Therapeutics Inc, which was acquired by Novo Nordisk on October 14, 2022, Novo Nordisk A/S. This abstract was presented at the American Physiology Summit 2025 and is only available in HTML format. There is no downloadable file or PDF version. The Physiology editorial board was not involved in the peer review process.
Lesbian, Gay, Bisexual, Transgender, Queer, and Other Sexual and Gender Minority Health Disparities
There is a context-dependent trade-off in body size of elite runners, such that smaller body sizes are observed among longer distance runners. However, it is unclear whether this trade-off in body size is observed in other Olympic sports, such as cycling and swimming. To understand the association between body size and athletic competition, we examined metrics of body size from male and female Olympic athletes competing in swimming, running, and cycling. We collected standard anthropometrics (height, mass, body mass index (BMI), and body surface area) of elite male and female athletes competing in the London 2012 Summer Olympics from a public repository. Anthropometric data were compared between sexes (male and female); between sports (swimming, running, and cycling); and between distances within sports (shorter and longer distance). Males were taller ( P < 0.001), heavier ( P < 0.001), and had a larger BMI ( P < 0.001) compared to females. Relative to athletes competing in longer distance events, athletes competing in shorter distance were generally taller (running: P < 0.001, swimming: P ≤ 0.014) and heavier (running: P < 0.001, swimming: P = 0.002 (males) and P = 0.148 (females), cycling: P < 0.001) for both males and females. Height was not different between shorter and longer distance cyclists. There was a trade-off between body size and distance for each of the three Olympics sports, such that smaller athletes were observed in longer distance events. Although there were large sex-based differences in body size, similar trade-offs in size and event were observed for both males and females. These data suggest that there is an optimal combination of skeletal muscle mass and body size to optimize movement economy that is generally preserved across different modes of human locomotion.
Abstract Objectives The aim of this study was to compare the measured physiological factors that limit running performance with real marathon results from world-class distance runners, evaluating the compatibility between measured data and predicted results based on the previously suggested model. Methods Four world-class East African marathon runners (three male, one female) underwent physiological running assessments to predict marathon performance times using a model based on V ˙ $\dot {\mathrm{V}}$ O 2 peak, percentage of V ˙ $\dot {\mathrm{V}}$ O 2 peak at the second ventilatory threshold, and running economy. Predictions were then compared to participants’ best marathon times. Results The measured V ˙ $\dot {\mathrm{V}}$ O 2 peak of the world-class runners was 75.1 ± 2.7 mL/kg/min. The second ventilatory threshold occurred at 85 ± 3 % of the peak, with a running economy of 63.7 ± 2.4 mL/kg/min at 19.6 ± 0.9 km/h. The predicted marathon performance time was 2:06:51 ± 0:03:17 h:min:s for the males and 2:17:36 h:min:s for the female. Comparing these predictions to their personal best times, the average difference was 00:55 ± 00:51 min:s (range: 00:20-02:08). Conclusions This research provides laboratory data on world-class road running athletes, reinforcing the link between marathon performance and V ˙ $\dot {\mathrm{V}}$ O 2 peak, the percentage of V ˙ $\dot {\mathrm{V}}$ O 2 peak at the second ventilatory threshold, and running economy. The examined athletes had lower V ˙ $\dot {\mathrm{V}}$ O 2 peak compared to predicted values, highlighting the importance of running economy and fractional utilization of V ˙ $\dot {\mathrm{V}}$ O 2 peak in achieving such performances. Future studies should continue to advance the field by including additional bioenergetic parameters measured during race conditions and expanding the participant cohort of elite marathoners, encompassing both sexes.
Neural Control of the Circulation: How Sex and Age Differences Interact in Humans